S-nitrosylation is required for β2AR desensitization and experimental asthma

Abstract

The β₂-adrenergic receptor (β₂AR), a prototypic G-protein-coupled receptor (GPCR), is a powerful driver of bronchorelaxation, but the effectiveness of β-agonist drugs in asthma is limited by desensitization and tachyphylaxis. We find that during activation, the β₂AR is modified by S-nitrosylation, which is essential for both classic desensitization by PKA as well as desensitization of NO-based signaling that mediates bronchorelaxation. Strikingly, S-nitrosylation alone can drive β₂AR internalization in the absence of traditional agonist. Mutant β₂AR refractory to S-nitrosylation (Cys265Ser) exhibits reduced desensitization and internalization, thereby amplifying NO-based signaling, and mice with Cys265Ser mutation are resistant to bronchoconstriction, inflammation, and the development of asthma. S-nitrosylation is thus a central mechanism in β₂AR signaling that may be operative widely among GPCRs and targeted for therapeutic gain.

Keywords: S-nitrosylation; airway hyperreactivity; asthma; beta-agonist; caveolae; desensitization; nitric oxide; receptor internalization; β(2)-adrenergic receptor.